Literature DB >> 7397063

Kinetic disposition and diuretic effect of frusemide in acute pulmonary oedema.

J Perez, D S Sitar, R I Ogilvie.   

Abstract

The kinetic disposition and diuretic effect of frusemide was assessed in 16 patients with acute pulmonary oedema utilizing a specific gas-liquid chromatographic assay for the drug. Serum frusemide concentrations decayed biexponentially with wide variation in both alpha half-life (range 15-79 min) and beta half-life (range 127-1190 min). The beta phase half-life was inversely related to creatine clearance. The apparent volume of distribution varied greatly among the patients (range 0.085-0.818 l/kg), and patients with an acute myocardial infarction had a larger peripheral kinetic compartment. Patients with acute myocardial infarction excreted less unchanged drug and had a lesser urinary excretion of sodium and volume compared to patients without infarction. The urinary excretion of sodium, chloride, calcium and volume was linearly related to the urinary excretion of unchanged frusemide.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7397063      PMCID: PMC1429944          DOI: 10.1111/j.1365-2125.1980.tb05842.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  21 in total

1.  Diuretic properties of furosemide in renal disease.

Authors:  R G Muth
Journal:  Ann Intern Med       Date:  1968-08       Impact factor: 25.391

2.  Furosemide effect on isolated perfused tubules.

Authors:  M Burg; L Stoner; J Cardinal; N Green
Journal:  Am J Physiol       Date:  1973-07

3.  Controlled study comparing ethacrynic acid to mercaptomerin in the treatment of acute pulmonary edema.

Authors:  M Lesch; G J Caranasos; J H Mulholland
Journal:  N Engl J Med       Date:  1968-07-18       Impact factor: 91.245

4.  Acute treatment of hypercalcemia with furosemide.

Authors:  W N Suki; J J Yium; M Von Minden; C Saller-Hebert; G Eknoyan; M Martinez-Maldonado
Journal:  N Engl J Med       Date:  1970-10-15       Impact factor: 91.245

5.  [Effect of furosemide on the urinary excretion of calcium].

Authors:  H Toft; J Roin
Journal:  Nord Med       Date:  1970-11-05

6.  Diuretics in chronic renal disease: a study of high dosage frusemide.

Authors:  M E Allison; A C Kennedy
Journal:  Clin Sci       Date:  1971-09       Impact factor: 6.124

7.  [Treatment of a case of acute hypercalcemia with furosemide].

Authors:  J R Le Gall; J C Raphaël; G Offenstadt; G A Marcel; F Mignon; J M Métreau; J P Bader; M Rapin
Journal:  Ann Med Interne (Paris)       Date:  1971-05

8.  The metabolic and respiratory acidosis of acute pulmonary edema.

Authors:  A Aberman; M Fulop
Journal:  Ann Intern Med       Date:  1972-02       Impact factor: 25.391

Review 9.  Treatment of hypercalcemias.

Authors:  M Walser
Journal:  Mod Treat       Date:  1970-05

10.  Absorption and excretion of furosemide-S35 in human subjects.

Authors:  B Calesnick; J A Christensen; M Richter
Journal:  Proc Soc Exp Biol Med       Date:  1966-10
View more
  7 in total

Review 1.  Effects of cardiovascular disease on pharmacokinetics.

Authors:  V Rodighiero
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

Review 2.  Diuretics. Clinical pharmacology and therapeutic use (Part I).

Authors:  A Lant
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

3.  The influence of age on renal and extrarenal effects of frusemide.

Authors:  F Andreasen; U Hansen; S E Husted; C E Mogensen; E B Pedersen
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

Review 4.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

5.  In vitro studies on the hydrolysis of frusemide in gastrointestinal juices.

Authors:  F Andreasen; H E Bøtker; K Lorentzen
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 6.  The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.

Authors:  A Bodenham; M P Shelly; G R Park
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

Review 7.  Furosemide pharmacokinetics and pharmacodynamics in health and disease--an update.

Authors:  M Hammarlund-Udenaes; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1989-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.